Tinzaparin: Clinical Trials

11 trials of Tinzaparin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 2 unknown, 1 recruiting. 11 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 6, Terminated 2, Unknown 2, Recruiting 1
Phase 32Completed 2
Phase 11Unknown 1

Follow Tinzaparin: new trials by email Literature Review of Tinzaparin trials Research Report on Tinzaparin

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
Tinzaparin Injectable Solution - Epithelial Ovarian Cancer
Phase 2RecruitingUniversity Hospital, Linkoeping402022-07-122026-05-11
ANTIcoagulation in Severe COVID-19 Patients
Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose prophylactic anticoagulation, Tinzaparin,Therapeutic anticoagulation - Severe COVID-19 Pneumonia
Phase 2CompletedAssistance Publique - Hôpitaux de Paris3532021-04-142022-09-08
Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
Tinzaparin or unfractionated heparin - COVID19 Pneumonia
Phase 2UnknownAssistance Publique - Hôpitaux de Paris8082020-04-202020-04-15
Study of Rivaroxaban for CeREbral Venous Thrombosis
Rivaroxaban, Standard of care - Cerebral Venous Thrombosis
Phase 2CompletedUniversity of British Columbia552019-03-122022-12-14
Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer
Tinzaparin, Blood sample - Lymphoma, Multiple Myeloma
Phase 2CompletedCentre Hospitalier Universitaire de Saint Etienne192015-04-142017-05-11
Anticoagulation Length in Cancer Associated Thrombosis
Low Molecular Weight Heparin (LMWH) - Cancer, Thrombosis
Phase 2TerminatedCardiff University22013-12-012018-10-29
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
tinzaparin sodium - Kidney Cancer
Phase 1 / Phase 2UnknownUniversity of Vermont352005-12-012013-11-06
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
Tinzaparin sodium - Venous Thromboembolism, Cancer
Phase 2TerminatedUniversity of Southern California1312005-07-012017-07-06
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery
Fragmin (dalteparin), Innohep (tinzaparin) - Thromboembolism, Hemodialysis
Phase 2 / Phase 3CompletedOttawa Hospital Research Institute292003-10-012014-09-10
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
Aspirin, tinzaparin sodium, eptifibatide - Ischemic Stroke
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)182003-05-012013-02-04
The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section
Tinzaparin - Deep Vein Thrombosis
Phase 2 / Phase 3CompletedOttawa Hospital Research Institute302002-07-012018-02-07

Conditions studied

Neoplasms (2)  ·  Venous Thromboembolism (2)  ·  Venous Thrombosis (2)  ·  COVID-19 (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Renal Cell (1)  ·  Hemorrhage (1)  ·  Intracranial Thrombosis (1)  ·  Ischemic Stroke (1)  ·  Kidney Failure, Chronic (1)  ·  Kidney Neoplasms (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)  ·  Pulmonary Embolism (1)  ·  Thromboembolism (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Ottawa Hospital Research Institute (2)  ·  Cardiff University (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  University Hospital, Linkoeping (1)  ·  University of British Columbia (1)  ·  University of Southern California (1)  ·  University of Vermont (1)

Countries

Canada (3)  ·  France (3)  ·  United States (3)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Anna Karlsson, MD (1)  ·  Anna-Clara Spetz Holm, MD, PhD (1)  ·  Deborah L. Ornstein, MD (1)  ·  Gabriel Lindahl, MD, PhD (1)  ·  Marc Rodger, MD (1)  ·  Marc Rodger, MD, MSc (1)  ·  Simon Noble, Dr (1)  ·  Steven Warach, MD, PhD (1)  ·  Thalia S Field, MD FRCPC (1)

Results publications

PMID 16458642, PMID 26490434, PMID 33502773, PMID 33779986, PMID 35244208, PMID 35473740, PMID 36946232, PMID 37675613, PMID 38189593

NIH funding

2014 (1)